Inventor · disambiguated record
Olaf Loge
Also filed as: LOGE OLAF · RADUCHEL BERND · SCHWARZ NORBERT · SKUBALLA WERNER
40 granted patents·766 citations·filing 1974–1995
98Inventor score
Files withSCHERING AG40
Top patents by PatentIndex Score
40 records- 0198US3960949A1,2-BiguanidesSCHERING AG·Filed 1974·Granted Jun 1, 1976·175 cites·7 claims
- 0296US4073934ANovel acetylenic prostaglandin analogsSCHERING AG·Filed 1976·Granted Feb 14, 1978·47 cites·82 claims
- 0394US6225347B19-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agentsSCHERING AG·Filed 1994·Granted May 1, 2001·57 cites·20 claims
- 0492US4256745ANew prostane derivatives and process for their preparationSCHERING AG·Filed 1978·Granted Mar 17, 1981·25 cites·22 claims
- 0592US4217360ANovel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereofSCHERING AG·Filed 1979·Granted Aug 12, 1980·28 cites·76 claims
- 0692US4004020ANovel prostanoic acid derivatives and process for the preparation thereofSCHERING AG·Filed 1974·Granted Jan 18, 1977·25 cites·29 claims
- 0791US4284646AProstanoic acid derivatives and their preparationSCHERING AG·Filed 1979·Granted Aug 18, 1981·22 cites·11 claims
- 0888US4489092AProstanoic acid derivatives and their preparationSCHERING AG·Filed 1982·Granted Dec 18, 1984·20 cites·38 claims
- 0988US4454339A9-Fluoroprostaglandin derivatives, and use as medicinal agentsSCHERING AG·Filed 1982·Granted Jun 12, 1984·31 cites·27 claims
- 1088US4235930ANovel acetylenic prostaglandins and processes for the preparation thereofSCHERING AG·Filed 1978·Granted Nov 25, 1980·32 cites·29 claims
- 1187US4699920A9-halo-2-prostaglandin derivatives, processes for the preparation thereof and use thereof as medicinal agentsSCHERING AG·Filed 1984·Granted Oct 13, 1987·31 cites·17 claims
- 1284US4359467AProstanoic acid derivatives and their preparationSCHERING AG·Filed 1981·Granted Nov 16, 1982·13 cites·21 claims
- 1382US4444788APharmaceutically active 9-chloroprostaglandinsSCHERING AG·Filed 1982·Granted Apr 24, 1984·19 cites·50 claims
- 1482US4346228ANovel 11-oxoprostaglandin derivativesSCHERING AG·Filed 1976·Granted Aug 24, 1982·11 cites·18 claims
- 1582US4219479A5-Cyano-prostacyclin derivativesSCHERING AG·Filed 1978·Granted Aug 26, 1980·19 cites·27 claims
- 1679US3962218ANovel prostanoic acid derivatives and processes for the preparation thereofSCHERING AG·Filed 1974·Granted Jun 8, 1976·10 cites·23 claims
- 1778US4870104A11-haloprostane derivatives, processes for their preparation and their use as medicinal agentsSCHERING AG·Filed 1986·Granted Sep 26, 1989·15 cites·23 claims
- 1877US4088775A15-Ethylenedioxy-prostanoic acid derivatives and esters thereof and intermediates thereofSCHERING AG·Filed 1975·Granted May 9, 1978·14 cites·90 claims
- 1975US5004752ANovel 9-haloprostaglandins, processes for their preparation, and their use as medicinal agentsSCHERING AG·Filed 1989·Granted Apr 2, 1991·21 cites·12 claims
- 2075US4191694AProstaglandin-I2 derivativesSCHERING AG·Filed 1978·Granted Mar 4, 1980·13 cites·60 claims
- 2170US4560786AΔ8,9 -Prostaglandin derivatives, their preparation and use as medicinal agentsSCHERING AG·Filed 1982·Granted Dec 24, 1985·12 cites·46 claims
- 2269US4789685A9-fluoroprostaglandin derivatives, their preparation and use as medicinal agentsSCHERING AG·Filed 1987·Granted Dec 6, 1988·13 cites·39 claims
- 2369US4364951AProstacyclins and use as medicinal agentsSCHERING AG·Filed 1981·Granted Dec 21, 1982·11 cites·18 claims
- 2464US5204371APharmaceutically active 9-chloroprostaglandinsSCHERING AG·Filed 1991·Granted Apr 20, 1993·8 cites·18 claims
- 2562US5891910A9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Apr 6, 1999·8 cites·18 claims
- 2662US4983629A11-haloprostane derivatives, processes for their preparation and their use as medicinal agentsSCHERING AG·Filed 1989·Granted Jan 8, 1991·6 cites·15 claims
- 2762US4021450AThiophene derivatives and their preparationSCHERING AG·Filed 1975·Granted May 3, 1977·4 cites·11 claims
- 2861US4159343AProstane derivativesSCHERING AG·Filed 1978·Granted Jun 26, 1979·5 cites·9 claims
- 2961US4031236ANovel thiophene derivatives and their preparationSCHERING AG·Filed 1975·Granted Jun 21, 1977·4 cites·18 claims
- 3058US5079259APharmaceutically active 9-chloroprostaglandinsSCHERING AG·Filed 1987·Granted Jan 7, 1992·7 cites·13 claims
- 3157US4894391ANovel prostacyclin derivatives, process for the preparation thereof, and use thereof as medicinal agentsSCHERING AG·Filed 1984·Granted Jan 16, 1990·6 cites·21 claims
- 3257US3984454ACrystalline prostanoic acid estersSCHERING AG·Filed 1974·Granted Oct 5, 1976·4 cites·12 claims
- 3354US5049582AProstacyclin derivatives with cytoprotective effect on liver, pancreas and kidneySCHERING AG·Filed 1989·Granted Sep 17, 1991·24 cites·4 claims
- 3450US5010065ACyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agentsSCHERING AG·Filed 1988·Granted Apr 23, 1991·14 cites·10 claims
- 3548US4835175AIndole derivatives pharmaceutical preparations based thereon, and β-receptor stimulation therewithSCHERING AG·Filed 1986·Granted May 30, 1989·4 cites·31 claims
- 3648US4105792AProstane dervativesSCHERING AG·Filed 1976·Granted Aug 8, 1978·2 cites·9 claims
- 3742US4721729ANovel carbacyclins, process for the preparation thereof, and their use as medicinal agentsSCHERING AG·Filed 1985·Granted Jan 26, 1988·3 cites·16 claims
- 3841US4058619AThiophene derivatives having antilipolytic activitySCHERING AG·Filed 1976·Granted Nov 15, 1977·1 cites·14 claims
- 3933US4154953ACrystalline prostanoic acid estersSCHERING AG·Filed 1977·Granted May 15, 1979·0 cites·9 claims
- 4028US5047525A9-haloprostaglandin clathrates and their use as medicinesSCHERING AG·Filed 1990·Granted Sep 10, 1991·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Olaf Loge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →